Pharmaceuticals

Fri, 09/03/2010 - 13:14

Bayer's SciLin insulin enters China market

Shanghai. September 3. INTERFAX-CHINA - Bayer Healthcare Co. Ltd. launched SciLin, a recombinant human insulin product, in China on Sept. 1, state media reported Sept. 2.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW